Mark Verdecia, MBA, PhD, Senior Scientific Writer, United States Pharmacopeia
Advertisement
Articles by Mark Verdecia, MBA, PhD, Senior Scientific Writer, United States Pharmacopeia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
5
